These authors contributed equally to this study
Development of Novel Tumor-Targeted Theranostic Nanoparticles Activated by Membrane-Type Matrix Metalloproteinases for Combined Cancer Magnetic Resonance Imaging and Therapy
Version of Record online: 27 AUG 2013
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Volume 10, Issue 3, pages 566–575, February 12, 2014
How to Cite
Ansari, C., Tikhomirov, G. A., Hong, S. H., Falconer, R. A., Loadman, P. M., Gill, J. H., Castaneda, R., Hazard, F. K., Tong, L., Lenkov, O. D., Felsher, D. W., Rao, J. and Daldrup-Link, H. E. (2014), Development of Novel Tumor-Targeted Theranostic Nanoparticles Activated by Membrane-Type Matrix Metalloproteinases for Combined Cancer Magnetic Resonance Imaging and Therapy. Small, 10: 566–575. doi: 10.1002/smll.201301456
- Issue online: 4 FEB 2014
- Version of Record online: 27 AUG 2013
- Manuscript Revised: 3 JUL 2013
- Manuscript Received: 10 MAY 2013
- NIH/NCI. Grant Numbers: R21CA156124, R01CA140943, R01CA135294, R21CA138353A2
As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.